Functional and clinical outcomes of nitinol stenting with and without abciximab for complex superficial femoral artery disease: A randomized trial

2006 ◽  
Vol 67 (2) ◽  
pp. 288-297 ◽  
Author(s):  
Gary M. Ansel ◽  
Mitchell J. Silver ◽  
Charles F. Botti ◽  
Krishna Rocha-Singh ◽  
Mark C. Bates ◽  
...  
Keyword(s):  
Randomized Trial ◽  
Clinical Outcomes ◽  
Femoral Artery ◽  
Superficial Femoral Artery ◽  
Artery Disease

Impact of Calcification on Clinical Outcomes After Endovascular Therapy for Superficial Femoral Artery Disease

2016 ◽  
Vol 23 (5) ◽  
pp. 731-737 ◽  
Author(s):  
Shota Okuno ◽  
Osamu Iida ◽  
Tatsuya Shiraki ◽  
Masashi Fujita ◽  
Masaharu Masuda ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Endovascular Therapy ◽  
Femoral Artery ◽  
Superficial Femoral Artery ◽  
Artery Disease

scholarly journals One-year outcomes of the U.S. and Japanese regulatory trial of the Misago stent for treatment of superficial femoral artery disease (OSPREY study)

2016 ◽  
Vol 63 (2) ◽  
pp. 370-376.e1 ◽  
Author(s):  
Takao Ohki ◽  
John F. Angle ◽  
Hiroyoshi Yokoi ◽  
Michael R. Jaff ◽  
Jeffrey Popma ◽  
...  
Keyword(s):  
Femoral Artery ◽  
Superficial Femoral Artery ◽  
Artery Disease ◽  
One Year ◽  
The U.S

scholarly journals Sustained drug retention after paclitaxel-coated balloon angioplasty for superficial femoral artery disease: Follow-up intravascular imaging

2020 ◽  
Vol 8 ◽  
pp. 2050313X2090782
Author(s):  
Norihiro Kobayashi ◽  
Keisuke Hirano ◽  
Masahiro Yamawaki ◽  
Motoharu Araki ◽  
Tsuyoshi Sakai ◽  
...  
Keyword(s):  
Frequency Domain ◽  
Femoral Artery ◽  
Balloon Angioplasty ◽  
Superficial Femoral Artery ◽  
Optical Frequency ◽  
Optical Frequency Domain Imaging ◽  
Drug Retention ◽  
Artery Disease ◽  
The Right

A 63 year-old woman with claudication underwent endovascular therapy for diffuse stenosis of the right superficial femoral artery in our hospital. We performed paclitaxel-coated balloon angioplasty using the IN.PACT™ Admiral™ and achieved acceptable results. After 42 days, we performed follow-up optical frequency domain imaging for the right superficial femoral artery lesion treated with paclitaxel-coated balloon and observed several high-intensity regions with attenuation on the lumen surface. Sustained drug availability is a notable characteristic of paclitaxel-coated balloon. To the best of our knowledge, this is the first report on the visualization of sustained drug retention on the lumen surface using follow-up optical frequency domain imaging after paclitaxel-coated balloon angioplasty in a human patient with superficial femoral artery disease.

Sign in / Sign up

Export Citation Format

Share Document